1. Home
  2. TEVA vs ERIE Comparison

TEVA vs ERIE Comparison

Compare TEVA & ERIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • ERIE
  • Stock Information
  • Founded
  • TEVA 1901
  • ERIE 1925
  • Country
  • TEVA Israel
  • ERIE United States
  • Employees
  • TEVA N/A
  • ERIE N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • ERIE Specialty Insurers
  • Sector
  • TEVA Health Care
  • ERIE Finance
  • Exchange
  • TEVA Nasdaq
  • ERIE Nasdaq
  • Market Cap
  • TEVA 21.2B
  • ERIE 19.2B
  • IPO Year
  • TEVA N/A
  • ERIE 1995
  • Fundamental
  • Price
  • TEVA $24.78
  • ERIE $293.06
  • Analyst Decision
  • TEVA Strong Buy
  • ERIE
  • Analyst Count
  • TEVA 7
  • ERIE 0
  • Target Price
  • TEVA $25.86
  • ERIE N/A
  • AVG Volume (30 Days)
  • TEVA 14.1M
  • ERIE 170.5K
  • Earning Date
  • TEVA 11-05-2025
  • ERIE 10-30-2025
  • Dividend Yield
  • TEVA N/A
  • ERIE 1.87%
  • EPS Growth
  • TEVA N/A
  • ERIE 15.90
  • EPS
  • TEVA 0.62
  • ERIE 12.39
  • Revenue
  • TEVA $16,776,000,000.00
  • ERIE $4,040,325,000.00
  • Revenue This Year
  • TEVA $4.11
  • ERIE $10.96
  • Revenue Next Year
  • TEVA $0.40
  • ERIE $8.12
  • P/E Ratio
  • TEVA $39.23
  • ERIE $23.56
  • Revenue Growth
  • TEVA 0.02
  • ERIE 9.53
  • 52 Week Low
  • TEVA $12.47
  • ERIE $276.91
  • 52 Week High
  • TEVA $26.38
  • ERIE $456.93
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 66.17
  • ERIE 45.44
  • Support Level
  • TEVA $24.01
  • ERIE $282.91
  • Resistance Level
  • TEVA $26.38
  • ERIE $301.61
  • Average True Range (ATR)
  • TEVA 0.91
  • ERIE 6.68
  • MACD
  • TEVA -0.08
  • ERIE 1.99
  • Stochastic Oscillator
  • TEVA 55.03
  • ERIE 61.62

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About ERIE Erie Indemnity Company

Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.

Share on Social Networks: